ReviewRedox biology2021

The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes.

Jorge D ErusalimskyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.